Open access
Aug 2026
Novel genomic score predicts survival with immune checkpoint inhibition in neuroendocrine neoplasms
Abstract Background Immune checkpoint inhibition (ICI) has activity in Grade 3 (G3) neuroendocrine neoplasms (NENs), but predictive biomarkers of long-term overall survival (OS) are currently lacking. Methods We derived a genomic scoring system using a retrospective cohort of 54 NEN patients treated with nivolumab and/...
Tanvi Brar, C. Olowookere, Dat Le et al.
· The Oncologist · 0 citations